Cargando…
Glioma targeting peptide modified apoferritin nanocage
Therapeutic outcome for the treatment of glioma was often limited due to the non-targeted nature of drugs and the physiological barriers, including the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB). An ideal glioma-targeted delivery system must be sufficiently potent to cross th...
Autores principales: | Zhai, Meifang, Wang, Yuli, Zhang, Ligang, Liang, Meng, Fu, Shiyao, Cui, Lin, Yang, Meiyan, Gong, Wei, Li, Zhiping, Yu, Lian, Xie, Xiangyang, Yang, Chunrong, Yang, Yang, Gao, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058491/ https://www.ncbi.nlm.nih.gov/pubmed/29726297 http://dx.doi.org/10.1080/10717544.2018.1464082 |
Ejemplares similares
-
Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery
por: Cui, Lin, et al.
Publicado: (2018) -
Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles
por: Liang, Meng, et al.
Publicado: (2018) -
Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers
por: Kurzątkowska, Katarzyna, et al.
Publicado: (2021) -
Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy
por: Yao, Hanchun, et al.
Publicado: (2016) -
Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity
por: Ji, Peng, et al.
Publicado: (2022)